Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Non Alcoholic – Beverages Market’s Growth Rate Evolve Over the Forecast Period to 2034?
The market size for non-alcoholic steatohepatitis (NASH) has seen considerable growth in the past few years. Its projected growth is from $4.5 billion in 2024 to an impressive $6.13 billion in 2025, with a compound annual growth rate (CAGR) of 36.1%. The historical growth of this market is due to the growing incidence of NASH, an increase in obesity, heightened awareness and diagnostic rates, alterations in lifestyle and eating habits, and the advancement of healthcare infrastructure.
Expectations are high for the non-alcoholic steatohepatitis (NASH) market, which is projected to experience exponential growth in the coming years. By 2029, it is envisaged to reach $19.07 billion, thanks to a compound annual growth rate (CAGR) of 32.8%. This growth can be linked to several factors such as advances in NASH drug development, the increase in NASH screening programs, rising health care spending, joint research initiatives, and supportive government policies. Major trends influencing this period of forecast include emphasis on lifestyle modifications and patient education, enhanced cooperation in clinical studies, regulatory progress and pathway designations, and the use of artificial intelligence in diagnosis and monitoring.
What Drivers Are Shaping the Growth of the Market?
The escalating incidences of obesity are fueling the demand in the non-alcoholic steatohepatitis (NASH) market. Obesity, characterized by abnormal or excessive fat accumulation that presents a health risk and body weight that exceeds the healthy or normal boundaries for a person’s height, is leading the charge. With non-alcoholic fatty liver disease becoming increasingly commonplace due to the spiraling obesity crisis, NASH could, in the upcoming years, become the primary cause of severe liver disease. This, in turn, elevates the requirement for NASH treatments and related medications. For example, as per the World Health Organization (WHO), an UK-based global public health institution, in March 2024, around 2.5 billion adults aged 18 and above were considered overweight in 2022, out of which 890 million were diagnosed with obesity. Hence, the escalating obesity rates are set to propel the growth of the non-alcoholic steatohepatitis (NASH) market.
Explore Comprehensive Insights Into The Global Non Alcoholic – Beverages Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8805&type=smp
Who Are the Influential Players Reshaping the Non Alcoholic – Beverages Market Landscape?
Major companies operating in the non-alcoholic steatohepatitis (NASH) market include:
• NGM Biopharmaceuticals Inc._x000D_
• Novartis AG_x000D_
• AstraZeneca plc._x000D_
• GlaxoSmithKline plc._x000D_
• F. Hoffmann-La Roche AG_x000D_
What New and Evolving Trends Are Having a Lasting Impact on the Non Alcoholic – Beverages Market?
Leading corporations in the non-alcoholic steatohepatitis (NASH) market are focusing on the creation of thyroid hormone receptor-beta (THR-beta) agonists to amplify liver metabolism, decrease liver fat storage, and boost liver function. These THR-beta agonists selectively trigger the thyroid hormone receptor-beta subtype, a crucial component in managing metabolism, growth, and development. In March 2024, for example, Rezdiffra (resmetirom), a THR-beta agonist, received approval from the US-based regulator, the Food and Drug Administration, for its use as the first line of treatment for adults suffering from noncirrhotic NASH with moderate to severe liver fibrosis. The selective activation of the THR-beta receptor by Rezdiffra aids in controlling lipid metabolism, resulting in a drop in intrahepatic triglycerides and overall lowering of liver fat accumulation.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Primary Segments of the Non Alcoholic – Beverages Market and Their Roles in Growth Dynamics?
The non-alcoholic steatohepatitis (NASH) market covered in this report is segmented –
1) By Type: Solid, Liquid
2) By Product: Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products
3) By Disease Cause: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
4) By Sales Channel: Hospital Pharmacy, Retail Pharmacy, Online Provider
5) By Application: Oral, Parenteral
Subsegments:
1) By Solid: Tablets, Capsules, Other Solid Dosage Forms
2) By Liquid: Oral Solutions, Syrups, Injectable Solutions, Other Liquid Dosage Forms
Which Geographic Locations Are Critical to the Growth of the Non Alcoholic – Beverages Market?
North America was the largest region in the non alcoholic steatohepatitis (NASH) market share in 2024. The regions covered in the non-alcoholic steatohepatitis (nash) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Do Experts Define the Scope of the Non Alcoholic – Beverages Market?
Non-alcoholic steatohepatitis (NASH) is a severe case of fatty liver disease that is characterized by inflammation of the liver and can proceed to cirrhosis and liver failure.
Browse Through More Similar Reports By The Business Research Company:
Non Alcoholic – Beverages Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-alcoholic-beverages-global-market-report
Alcoholic – Beverages Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alcoholic-beverages-global-market-report
Ethyl Alcohol And Other Basic Organic Chemical Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
